EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Inflammatory Scores as Diagnostic Markers for Polymyalgia Rheumatica

Ji-Won Kim, Ju-Yang Jung, Chang-Hee Suh iD, Hyoun-Ah Kim iD

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Ji-Won Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea. Hauptthemen laut MEDLINE: Polymyalgia Rheumatica, C-Reactive Protein, Inflammation Mediators, Arthritis, Rheumatoid. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Polymyalgia rheumatica (PMR) is a chronic inflammatory rheumatic disease affecting older adults, with symptoms often overlapping with those of other conditions, thus making its diagnosis challenging. The present study evaluated the utility of laboratory‐based inflammatory scores, including the systemic immune‐inflammation index (SII), C‐reactive protein‐to‐albumin ratio (CAR), albumin‐to‐globulin ratio (AGR), and prognostic nutritional index (PNI), as diagnostic tools for PMR and explored their association with clinical manifestations.

Methods

This retrospective study analyzed the medical records of 156 patients diagnosed with PMR and 408 diagnosed with rheumatoid arthritis (RA) between 2001 and 2021 to evaluate the diagnostic performance of inflammatory scores in distinguishing between the two conditions. Statistical analyses, including receiver operating characteristic (ROC) curve analysis and logistic regression, were used to assess the accuracy and effectiveness of the scores.

Results

Patients with PMR exhibited higher SII and CAR scores and lower AGR and PNI values than those with RA. CAR demonstrated the best diagnostic performance, with an area under the ROC curve (AUC) of 0.823 (95% confidence interval [CI], 0.784–0.861), followed by SII (AUC, 0.797 [95% CI, 0.757–0.837]), AGR (AUC, 0.696 [95% CI, 0.648–0.743]), and PNI (AUC, 0.691 [95% CI, 0.641–0.741]). Combining these scores improved diagnostic ability, with an AUC of approximately 0.835. Furthermore, elevated SII or CAR values and decreased AGR or PNI values were associated with leucocytosis, anemia, elevated erythrocyte sedimentation rate/C‐reactive protein, hypalbuminaemia, fever, weight loss, and headache.

Conclusions

Serological inflammatory scores, such as SII, CAR, AGR, and PNI, were useful as diagnostic markers for PMR, with combined scores enhancing overall diagnostic accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyalgia RheumaticaC-Reactive ProteinInflammation MediatorsArthritis, RheumatoidHumansFemaleMaleRetrospective StudiesAgedBiomarkersMiddle AgedPredictive Value of TestsAged, 80 and overReproducibility of ResultsNutrition AssessmentNutritional StatusDiagnosis, DifferentialPrognosisSerum Albumin, HumanSerum Albumin

Stichwörter der Autor:innen

diagnostic markerinflammatory scorespolymyalgia rheumatica

Substanzen

BiomarkersC-Reactive ProteinInflammation MediatorsSerum Albumin, HumanSerum Albumin

Autor:innen und Institutionen

  • Department of Rheumatology, Ajou University School of Medicine, Suwon, Korea.

ORCID-Profile: Chang-Hee Suh, Hyoun-Ah Kim

Zitieren

APA

Kim, J. W., Jung, J. Y., Suh, C. H., & Kim, H. A. (2025). Evaluation of Inflammatory Scores as Diagnostic Markers for Polymyalgia Rheumatica. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70153

Vancouver

Kim JW, Jung JY, Suh CH, Kim HA. Evaluation of Inflammatory Scores as Diagnostic Markers for Polymyalgia Rheumatica. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70153

BibTeX
@article{Kim2025,
  author = {Kim, Ji-Won and Jung, Ju-Yang and Suh, Chang-Hee and Kim, Hyoun-Ah},
  title = {Evaluation of Inflammatory Scores as Diagnostic Markers for Polymyalgia Rheumatica},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70153}
}
Kostenlos starten →